IntelGenx Corp.

Oral controlled-release drug delivery technologies have the ability to improve the performance of a wide variety of existing pharmaceutical compounds. The therapeutic effect of a drug compound will typically vary according to its bloodstream concentration. When the concentration is too low, efficacy may be reduced and when it is too high, side effects may increase.

We are proud of our ability to provide and develop a wide and highly diverse range of products catering for present and future commercial needs. Our rapidly growing product pipeline consists of products at various stages of development from inception to commercialization. We are working closely with our partners in developing seven major products and are in negotiations to extend and develop partnerships for some of our other products.